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Abstract
Several studies have examined associations between peripheral DNA methylation patterns of the serotonin transporter
gene (SLC6A4) promoter and symptoms of depression and anxiety. The SLC6A4 promoter methylation has also been
associated with frontal-limbic brain responses to negative stimuli. However, it is unclear how much of this association
is confounded by DNA sequence variations. We utilized a monozygotic-twin within-pair discordance design, to test
whether DNA methylation at specific CpG sites in the SLC6A4 promoter of peripheral cells is associated with greater
frontal-limbic brain responses to negative stimuli (sadness and fear), independently of DNA sequence effects. In total
48 pairs of healthy 15-year-old monozygotic twins from the Quebec Newborn Twin Study, followed regularly since
birth, underwent functional magnetic resonance imaging while conducting an emotion-processing task. The SLC6A4
promoter methylation level was assessed in saliva samples using pyrosequencing. Relative to the co-twins with lower
SLC6A4 promoter methylation levels, twins with higher peripheral SLC6A4 methylation levels showed greater
orbitofrontal cortical (OFC) activity and left amygdala-anterior cingulate cortex (ACC) and left amygdala-right OFC
connectivity in response to sadness as well as greater ACC-left amygdala and ACC-left insula connectivity in response
to fearful stimuli. By utilising a monozygotic-twin design, we provided evidence that associations between peripheral
SLC6A4 promoter methylation and frontal-limbic brain responses to negative stimuli are, in part, independent of DNA
sequence variations. Although causality cannot be determined here, SLC6A4 promoter methylation may be one of the
mechanisms underlying how environmental factors influence the serotonin system, potentially affecting emotional
processing through frontal-limbic areas.
Introduction
Animal and human studies suggest that environmental
exposures can affect our epigenome and these epigenetic
marks can persist through cell divisions1. Epigenetic
modifications can change gene expression without alter-
ing the genetic sequence. These epigenetic modifications
play an important role in setting up tissue- and cell type-
specific gene expression programs during development
and are crucial in maintaining normal cellular physiol-
ogy2. DNA methylation—as one of these possible epige-
netic mechanisms—implies a covalent modification of the
DNA molecule itself through enzymatic addition of a
methyl group to (mostly) cytosine bases2. DNA methyla-
tion, involved in epigenetic regulation of gene expression,
at critical regulatory regions such as promoters and
enhancers, can lead to permanent silencing of the gene,
either directly by blocking transcriptional factors from
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binding to the DNA sequence or by attracting proteins to
form corepressor complexes3,4.
DNA methylation patterns are shaped during develop-
ment and cellular differentiation but are also responsive
to environmental signals, particularly during gestation5.
Indeed, even in newborns, variations in DNA methylation
levels can be detected across twins, suggesting that
environmental factors might be influencing the normal
developmental trajectories of DNA methylation pattern6.
DNA methylation alterations in response to early envir-
onmental exposure also appear to be stable, at least in
some gene regions, for many years. For example, a study
in humans has shown that individuals who were exposed
to the Dutch famine in the perinatal period had, six
decades later, altered DNA methylation in particular sites
compared to their non-exposed siblings7.
One of the most widely studied genes in relation to
DNA methylation and mental health is the serotonin
transporter gene, SLC6A4. The serotonin transporter is of
interest as it has been shown to play an important role in
mood, cognition and psychophysiology, as well as brain
development8. Following results of association studies
showing a link between SLC6A4 methylation assessed
from peripheral cells and early life environment and later
behavior in human clinical and nonclinical popula-
tions9,10, a number of studies have now investigated
possible associations between peripheral SLC6A4 methy-
lation and brain processes. For instance, Wang et al.11
found that SLC6A4 promoter methylation in T lympho-
cytes of adults was associated with lower in vivo Positron
Emission Tomography (PET) measures of brain serotonin
(5-hydroxytryptamine; 5-HT) synthesis in the orbito-
frontal cortex and higher childhood aggression. Further-
more, a recent study found associations between SLC6A4
methylation and in vivo PET measures of serotonin
transporter availability12. We also previously reported that
SCL6A4 methylation obtained from white blood cells was
significantly associated with activation in response to
negative emotional stimuli in the insula13 and lower
hippocampal volume14 in depressed patients and controls.
Using functional magnetic resonance imaging (fMRI),
greater peripheral SLC6A4 methylation from saliva and
whole-blood DNA samples has also been associated with
an increased amygdala response to threat-related stimuli
in adolescents and young adults15,16. In one (f)MRI study,
we reported that greater peripheral SLC6A4 methylation
from whole-blood, saliva, and buccal DNA samples have
been associated with greater (superior) prefrontal cortical
GM volume and parietal-frontal regional functional con-
nectivity at rest in healthy adults17. Together, these find-
ings support the relevance of peripheral SLC6A4
methylation measures for frontal-limbic brain processes
and support the notion that SLC6A4 methylation level
changes may be an underlying mechanism of how
environmental factors can influence aspects of the 5-HT
system and, consequently, emotion processing.
However, these associations could be confounded by the
effects of variations in DNA sequence. Indeed, certain
genotypic variants have been shown to have different
DNA methylation patterns than others in the context of
similar exposures and experiences18. For instance, lower
methylation was found in association with unresolved
trauma or loss in individuals with the s/s genotype of the
SLC6A4 promoter polymorphism, while an inverse cor-
relation was found in the l/l genotype group18. Further-
more, the influence of DNA sequence on methylation
status may depend on genomic location, cell type, and
developmental stage19.
Monozygotic (MZ) twin study designs are unique in
their ability to control for DNA sequence differences
because each pair of MZ twins shares essentially the same
genetic sequence. Thus, differences within twin pairs in
gene expression and phenotype, including brain pro-
cesses, can be attributed to environmental effects rather
than DNA sequence influences.
In the present study, we utilized a MZ design to test, in a
sample of healthy adolescents, whether DNAmethylation at
the SLC6A4 promoter in peripheral cells is associated with
greater frontal-limbic activation and connectivity in
response to negative stimuli, irrespective of DNA sequence
differences. Specifically, we focused on sad and fearful sti-
muli because neural responses to these negative emotional
facial expressions have been relatively consistently asso-
ciated with SLC6A4 genetic and epigenetic variation13,15,20.
Subjects and methods
Participants were 96 monozygotic twins (48 pairs: 21
male and 27 female pairs; age 15 years) from the Quebec
Newborn Twin Study (QNTS)21,22, followed long-
itudinally since birth, in the area of Montreal, Canada,
between April 1995 and December 1998. The number of
individuals (n= 96, 48 pairs) was larger than the sample
size of our previous studies in non-twins and that focused
on SLC6A4 methylation and its link with brain processes
(e.g., 13, 17). They were all physically healthy, free of any
medication liable to affect brain function and free of
current and past psychopathology. Mental health status
was confirmed by the Schedule for Affective Disorders
and Schizophrenia for School-Age Children- Present and
Lifetime Version (K-SADS)23. Furthermore, we used the
Dominic Interactive (Adolescent version), a computerized
questionnaire to assess subclinical levels of internalizing
symptoms (phobias, generalized anxiety and depres-
sion)24. The appropriate ethics committees (CHU Sainte-
Justine and Montreal Neurological Institute) approved the
research protocol. Written assent was obtained from all
participants and written consent from parents of all
participants.
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DNA methylation protocol
Whole saliva was collected using the Oragene TM DNA
self-collection kit following manufacturer instructions
(DNA Genotek Inc., 2004, 2006). Participants did not eat,
chew gum, or drink anything but water for 30min prior to
saliva collection. Once extracted, whole-saliva DNA was
converted with EZ DNA Methylation-Gold Kit (D5006,
Zymo Research, Irvine, CA, USA). Following recom-
mendation by Tost and Gut25, 20 ng of bisulfite-treated
DNA was used in the PCR amplification to reach high
reproducibility of pyrosequencing, using previously pub-
lished primer sets optimized for bisulfite-treated DNA
template (11, Fw: 5′TTGTTAGGTTTTAGGAAGAAA-
GAGAGA-3′, Rev: 5′Biosg-AAAAAAACTACACAAAAA
AACAAATATAC-3′) with EpiMark Hot Start Taq DNA
Polymerase (New England Biolabs, Ipswich, MA, USA).
Ten CpG sites (numbered as 5–14) in the
28563060–28563221 region of chromosome 17 (accord-
ing to hg19) were assayed.
Site-specific methylation analyses were performed by
pyrosequencing using PyroMark Q96 (Qiagen, Venlo,
Limburg, Netherlands) using the CFI Imaging and
Molecular Biology Platform at McGill University in the
Department of Pharmacology and Therapeutics using
2 sequencing primers: 5′AAGAGAGAGTAGTTT-3′ and
5′GTAGATTTTTGTGTG-3′. The DNA methylation
level at each CpG site was computed after quality control
of the triplicates. If a sample did not pass quality control
at a certain CpG site, the mean DNA methylation value
for that CpG site was calculated from the remaining two
replicates. We then computed the average methylation
level from our ten CpG sites of interest (CpG sites 5–14).
In line with other studies that linked brain processes with
SLC6A4 methylation13,16,17,26, average methylation levels
across the investigated CpG sites values were calculated
and used in the analyses. The average value of promoter
methylation level was used in the analyses rather than the
DNA methylation level of each individual CpG site to
limit the number of statistical comparisons. The choice to
calculate the mean of the ten studied CpG sites was fur-
ther based on our previous work in healthy and clinical
samples, showing associations between average SLC6A4
methylation levels across these 10 sites and in vivo mea-
sures of brain 5-HT synthesis in the frontal-limbic brain
circuits as well as frontal-limbic functional and structural
processes11,1317.
Neuroimaging
Participants were scanned on a 3 T Siemens TIM Trio
Scanner located at the Montreal Neurological Institute
(MNI) with a 32-channel head coil. The scan included a
magnetization-prepared rapid acquisition gradient-echo
(MPRAGE) 9 min sequence (176 slices, 1 mm thickness,
TR= 2300ms, TE= 2.98 ms, TI= 900 ms, FA= 9°, FOV
= 256 × 256mm, matrix size 256 × 256) to assess brain
anatomy. Next, a 15-min functional scan during an event-
related emotion-processing task, adapted from the task
used in Canli and colleagues27, was performed. Briefly, the
task consisted of a series of 120 Ekman faces with dif-
ferent emotions (happy, sad, angry, fearful, and neutral)
from the Pictures of Facial Affect series28. Faces were
presented randomly for 2 s and followed by a fixation
cross (~2 s; jittered) and a question asking whether the
face belonged to a man or a woman. Two hundred and 26
functional whole-brain images (multi-slice gradient echo
EPI with 3.5 mm isotropic resolution and TR/TE= 2110/
30ms, 40 slices, FOV= 224 × 224 mm, matrix size 64 ×




Pre-processing steps (slice timing and motion correc-
tion, coregistration with the anatomical scan, normal-
ization into an EPI stereotactic Space (MNI template) and
spatial smoothing at 7 mm FWHM with a Gaussian
Kernel were performed in SPM8 (Wellcome Department
of Cognitive Neurology, London UK). For each emotion,
activation during neutral stimuli was subtracted from the
activation during the different emotions. Voxel-wise sad
minus neutral and fear minus neutral contrasts were
generated at the first level. We calculated within-pair
discordance by subtracting the activation contrast of the
twin with higher SLC6A4 methylation levels from the
activation contrast of the co-twin with lower SLC6A4
methylation levels29. Discordance values were then used
in the regression analyses, by regressing discordance in
brain activation in response to sadness>neutral and
fear>neutral independently onto discordance in methyla-
tion. Whole-brain analysis was conducted. The threshold
p value was set at p < 0.001. Only clusters showing a
spatial extent of at least 10 contiguous voxels were con-
sidered (except for the amygdala, in which we required at
least 5 contiguous voxels). We corrected for multiple
comparisons at the cluster level using the family-wise
error rate (FWE)30.
Functional connectivity
Following the pre-processing steps, functional con-
nectivity analyses were performed using the CONN
Functional Connectivity toolbox v174 (http://www.nitrc.
org/projects/conn). We controlled for the possible con-
founding effects of head motion artifacts using the
ComCor strategy and default preprocessing para-
meters31,32. In addition, we applied the following denois-
ing options in CONN: detrending, which removes linear/
quadratic/cubic trends within each functional session, and
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despiking, which applies a squashing function to reduce
the influence of potential outlier scans32.
We conducted ROI-to-ROI analyses to assess functional
connectivity during sad and fearful conditions. The fol-
lowing ROIs were chosen, namely bilateral amygdala,
bilateral orbitofrontal cortex (OFC), anterior cingulate
cortex (ACC) and bilateral insula. Amygdala was chosen
in light of the link between peripheral SLC6A4 methyla-
tion and amygdala responses to fearful stimuli in (non-
twin) adolescents16. OFC was of particular interest in light
of the results of our study in healthy (non-twin) indivi-
duals showed an association between lower brain ser-
otonin synthesis in the OFC and greater peripheral
SLC6A4 methylation11. ACC was chosen given the find-
ings of activation in this region during sadness in (non-
twin) individuals with depressive symptoms33,34. Insula
was chosen based on our previous study showing an
association between insula response to negative stimuli
and peripheral SLC6A4 methylation in (non-twin) healthy
and depressed adults13. Mean BOLD time series were
extracted from each ROI and correlated with the BOLD
time-series signal of every other ROI in the network to
create a ROI-to-ROI connectivity matrix (connectome)
showing connectivity between each region within the
network.
In order to assess discordance between ROI-to-ROI
connectivity values based on peripheral SLC6A4 promoter
methylation discordance, ROI-to-ROI connectivity for
twins with greater SLC6A4 methylation level was com-
pared to their co-twins with lower methylation level.
Given the sample size and the correlational nature of
functional connectivity and to balance the risk for type I
and type II errors, we set the statistical threshold for each
voxel at p < 0.05, uncorrected.
Results
DNA methylation
The mean SLC6A4 promoter methylation level was
3.74% (SD= 2.37, range: 1.23–14.37%). This level is
comparable to that found in other peripheral SLC6A4
promoter methylation studies, derived from various bio-
logical tissues including saliva, using the same CpG
sites11,1317. Within pair, the average discordance in
SLC6A4 promoter methylation varied from 0.23 to 8.58%.
There were no sex differences in mean SLC6A4 methy-
lation levels (F(1,94)= 0.01, p= 0.98), nor in SLC6A4
methylation discordance levels (F(1,46)= 2.53, p= 0.12).
Mean level of internalizing symptoms on the Dominic
scale was 10.30 (SD= 6.16, range 1–27 out of maximum
total score of 52), indicative of absent/low likelihood of
internalizing symptomatology. Within pair, the average
discordance in symptoms was 4.37 points (SD= 3.39,
range 0–15). SLC6A4 promoter methylation did not
correlate with internalizing symptoms (as assessed by the
Dominic Interactive questionnaire) neither globally (r=
0.12, p= 0.25) nor within pair (r= 0.12, p= 0.42).
fMRI results
Sad condition
Relative to their co-twin with lower methylation, twins
with higher SLC6A4 promoter methylation levels had
greater left OFC activation (k= 206, t= 5.11, cluster
pFWE= 0.03) (Fig. 1), as well as greater functional con-
nectivity between left amygdala and ACC and between left
amygdala and right OFC (Fig. 2 and Table 1). No other
significant fMRI results were found in the sad condition.
Fearful condition
There was no significant association with neural activity
in the fearful condition. However, twins with higher
SLC6A4 promoter methylation level had greater func-
tional connectivity between ACC and left amygdala and
between ACC and left insula, relative to the co-twin with
lower SLC6A4 methylation (Fig. 3 and Table 1). No other
significant fMRI results were found in the fearful
condition.
Discussion
The aim of the present study was to assess potential
neural correlates of peripheral SLC6A4 promoter methy-
lation during processing of negative facial expressions, i.e.,
sadness and fear. While an emerging number of studies
have now shown that peripheral SLC6A4 methylation
correlates with frontal-limbic processing of negative
emotions, it is not clear whether this association is due to
Fig. 1 Greater within-pair difference in peripheral SLC6A4
promoter methylation was associated with greater responses to
sad stimuli in left orbitofrontal cortex (T= 5.11, pFWE= 0.032).
The color bar represents T values
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the environment or to genetic factors. Here, we utilized a
within-pair MZ-twin design to control for the putative
role of DNA sequence in this association. We found that
relative to the co-twins with lower SLC6A4 promoter
methylation, twins with greater SLC6A4 methylation
levels had greater left OFC activation, greater amygdala-
OFC and left amygdala-ACC connectivity in the sad
condition, as well as greater ACC-amygdala and ACC-
insula connectivity in the fearful condition. In spite of
relatively low within-pair variability, current findings are
of particular interest given the implication of these brain
regions in emotion regulation. Indeed, regional func-
tioning of OFC, ACC, insula and amygdala, all part of the
frontal-limbic circuitry, has previously been associated
with emotion regulation35,36 and SLC6A4 methylation16.
Our findings do not only support the previously suggested
hypothesis that peripheral SLC6A4 promoter methylation
shares potentially functional relevant information about
frontal-limbic functioning and emotion-processing, but,
most importantly, demonstrate for the first time that
these associations occur, at least in part, independently of
DNA sequence.
The finding of within-pair differences in neural pro-
cessing of sad stimuli in the OFC regions fits well with the
results of our previous study in which we compared
neural activation to sad stimuli between 8-year-old
monozygotic (MZ) and dizygotic (DZ) twins, allowing
separation of genetic factors from environmental factors
shared between twin pairs and non-shared environmental
factors that are unique for each twin member37. Among
other brain areas, neural activation during processing of
sad stimuli in Broadmann Area (BA) 47, a key region in
the OFC, was found to be fully driven by non-shared/
unique environmental factors37. Interestingly, results of a
positron emission tomography (PET) study, investigating
the neural basis of various emotions (sadness, happiness,
Fig. 2 Connectome ring representation of ROI-to-ROI connectivity between amygdala, anterior cingulate cortex (ACC), orbitofrontal
cortex (OFC) and insula in the sad condition. Only significant connectivity discordances are represented: greater ROI-to-ROI connectivity in the sad
condition for twins with greater methylation level compared to their co-twins with lower methylation level, between left amygdala and ACC (T=
1.83, p= 0.036), as well as between left amygdala and right OFC (T= 1.71, p= 0.047). The color bar represents T values. The bars plot in the top right-
hand corner represents differences in effect sizes (difference in Fisher-transformed correlation coefficients) between twins with greater methylation
level and their co-twins with lower methylation level, for each connection









Positive: Fearful ACC-left amygdala 2.79 0.004
ACC-left insula 1.85 0.035
fMRI functional Magnetic Resonance Imaging, SLC6A4 serotonin transporter
gene, OFC orbitofrontal cortex, ACC anterior cingulate cortex
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anger and fear) in healthy individuals, showed that the
orbitofrontal regional activity was found to peak solely
during the sadness condition38, emphasizing the role of
the OFC in the detecting and processing of sad stimuli.
That being said, in addition to the OFC, Damasio and
colleagues38 reported increases in insula and ACC activity
during sad condition (and, respectively, during fearful and
angry condition). The absence of these insula-ACC
regional responses to sad or fearful cues in the current
study may be, in part, explained by differences in meth-
odology (e.g., use of current implicit emotion-processing
task versus self-generated emotional conditions by recall).
Furthermore, we previously found—using in vivo PET
measures of brain 5-HT synthesis—that serotonergic
synthesis in the OFC is not only modulated by DNA
sequence39 but also by early environmental factors40. The
environmental influences on serotonin functioning in the
OFC observed in the present study also fits well with our
previous PET study showing that greater peripheral
SLC6A4 methylation correlated with lower in vivo brain
serotonin synthesis in the OFC region11. Current findings
are also in line with the results of a study by another
research group reporting positive association between
peripheral SLC6A4 promoter methylation and resting-
state functional connectivity between amygdala, insula
and ACC in healthy adults26. Notably, OFC, ACC, insula
and amygdala constitute an integral part of the salience
functional network, involved in affective processes41.
Interestingly, results of an fMRI study examining neural
correlates of emotion regulation in healthy individuals,
showed that functional connectivity between amygdala
and several (pre)frontal regions, including OFC and ACC,
was associated with attenuated emotional response to
negative emotional stimuli41, thereby underscoring the
involvement of frontal-limbic functional connectivity in
processing and regulation of emotions. Interestingly, sal-
ience network has been found to show relatively low
cross-twin correlation in both MZ and DZ twins42, indi-
cative of scarce evidence for either genetic or non-shared
environmental effect on this network. Results of the
present study suggest that this SLC6A4-related salience
network is, at least in part, independent of variation in
DNA sequence. Altogether the findings suggest an
important role for OFC, ACC, and amygdala in the
Fig. 3 Connectome ring representation of ROI-to-ROI connectivity between anterior cingulate cortex (ACC), left amygdala and insula in
the fearful condition. Only significant connectivity discordances are represented: greater ROI-to-ROI connectivity in the fearful condition for twins
with greater methylation level: between ACC and left amygdala (T= 2.79, p= 0.004), as well as between ACC and left insula (T= 1.85, p= 0.035). The
color bar represents T values. The bars plot in the top right-hand corner represents differences in effect sizes (difference in Fisher-transformed
correlation coefficients) between twins with greater methylation level and their co-twins with lower methylation level, for each connection
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processing of sadness and fear, which appear to be partly
driven by SLC6A4-modulated non-shared/unique envir-
onmental factors.
Some laterality effects were observed as well. Notably,
the finding that the association in the amygdala was spe-
cific for the left side is in line with other research showing
that the left amygdala is more frequently activated in
response to emotional stimuli than the right amygdala (see
ref. 43 for meta-analysis). Furthermore, stronger functional
connectivity between left (but not right) amygdala and
bilateral ACC and OFC has been associated with
decreased negative affect induced by negative emotional
content in healthy individuals44. Besides, conjoint activity
of ACC and left (but not right) insula has been linked to
increased awareness of one’s own emotions45. Interest-
ingly, greater SLC6A4 promoter methylation has been
previously linked to greater left (but not right) amygdala
and insula activation in response to negative emotional
stimuli13,16. In light of these findings, we might advance
that these lateralized regional activities reflect serotonin
functioning-related neurobiological processing of the (sad
or fearful) emotionally salient content. However, addi-
tional SLC6A4 methylation fMRI studies of the con-
nectivity of amygdala, OFC and insula subdivisions are
necessary to deepen the understanding of the laterality.
While we found significant associations between per-
ipheral SLC6A4 promoter methylation discordance and
neural processing of negative stimuli, we did not find any
correlations between depressive symptoms and peripheral
SLC6A4 methylation. However, the levels of symptoma-
tology variation were very low. The observation of an
association between SLC6A4 methylation and neural
processing of negative stimuli in the absence of an asso-
ciation with anxiety- or depression-related symptoms is
consistent with studies that include healthy individuals
(e.g., 16). Thus, variation in frontal-limbic brain activa-
tion, as a function of variation in SLC6A4, occurs in the
absence of behavioral variation. This supports the idea
that SLC6A4 methylation could reflect a marker for
neural regulation of negative stimuli, but additional fac-
tors may be necessary for an overt behavioral phenotype
to be expressed8. Nevertheless, it would be of particular
interest to test MZ twins who are highly discordant in
levels of internalizing symptoms and in SLC6A4 promoter
methylation and link their discordance to differences in
frontal-limbic processes.
Furthermore, peripheral SLC6A4 promoter methylation
levels and methylation differences within MZ twin pairs
were low. However, considering the binary (either
methylated or unmethylated allele at a particular CpG
site) nature of the DNA methylation, the percentage
change in DNA methylation indicates the fraction of cells
having possibly experienced a complete change in
methylation at a given site17. In other words, a small
increase in SLC6A4 promoter methylation of a tissue
sample may suggest that few cells are potentially turning
off their expression. Indeed, using an in vitro model,
higher DNA methylation levels in the selected SLC6A4
promoter region have been previously shown to lower its
transcriptional activity11, thereby corroborating the reg-
ulatory role of DNA methylation of this region. In addi-
tion, peripheral DNA methylation in this particular gene
region has been shown to be a potential marker of ser-
otonin synthesis in the OFC11.
The strengths of this study include the use of a well-
characterized, prospective, homogeneous longitudinal
sample of adolescents. All twins were 15 years of age and
carefully screened for the absence of psychiatric history.
Furthermore, the investigated SLC6A4 region and primary
CpG sites were chosen a-priori, based on previous work
and validation in vivo and in vitro in three independent
samples11,13,14,17. However, the present findings should
also be considered in the context of certain limitations.
First, methylation was assessed from peripheral tissue (i.e.,
saliva), as DNA methylation generally cannot be assessed
in the living human brain. However, studies combining
epignegative stimuli are detectable while controlling for
DNA sequenceenetics and various fMRI measures have
shown substantial correlations between methylation
assessed from peripheral tissue and brain functioning13–
17,46. Moreover, future studies will be necessary to inves-
tigate potential moderating roles of age, sex, and various
psychosocial variables, as well as to identify individual
participant characteristics that account for the within-pair
variation. Furthermore, we will continue to follow these
twins in the future to assess the clinical relevance of these
alterations in peripheral SLC6A4 promoter methylation
and processing of negative emotional stimuli. In spite of
these limitations, the findings in our MZ twin study
provide evidence that previously reported associations
between peripheral SLC6A4 promoter methylation and
frontal-limbic processing of negative stimuli are detect-
able while controlling for DNA sequence. These associa-
tions may have implications for the future use of non-
invasive DNA methylation markers in diagnosis, treat-
ment and risk prediction in mental health problems in
which serotonin plays an important role.
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